News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lev Pharmaceuticals, Inc. to Present at the Jefferies & Co. 2nd Annual Healthcare Conference


6/19/2008 9:49:43 AM

NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., chief executive officer of Lev will present at the Jefferies & Co. 2nd Annual Healthcare Conference, being held June 24-26 in New York City, NY. Dr. Schein will present a corporate progress report, including an update on the Company's lead product candidate, Cinryze™ [C1 inhibitor (human)]. The Lev presentation is scheduled to begin at 1:30 p.m. Eastern Standard Time on Thursday, June 26th.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES